IP Library › Granted Patent US 10,053,497
Granted Patent B2
US 10,053,497 · App. 10/516,837 · Granted Aug 21, 2018

Therapeutic epitopes and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,053,497
App. No.
10/516,837
Granted
Aug 21, 2018
Kind
B2
Abstract

The invention herein disclosed is related to epitopes useful in methods of diagnosing, treating, and preventing coeliac disease. Therapeutic compositions which comprise at least one epitope are provided.

Claims (1)

1. A method of treating coeliac disease in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a peptide comprising an amino acid sequence of transglutaminase-treated QQPFPQPQQPFPWQP (SEQ ID NO:779), wherein the peptide is 15 amino acids in length and wherein the subject is tolerised to a gliadin protein.

Assignments (2)
CHANGE OF NAME Recorded Aug 2, 2016
From: ISIS INNOVATION LIMITED
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 039550/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2005
From: ANDERSON, ROBERT PAUL; HILL, ADRIAN VIVIAN SINTON; JEWELL, DEREK PARRY
To: ISIS INNOVATION LIMITD
Reel/Frame 016623/0188 →